Literature DB >> 20847981

Minimized extracorporeal circulation for the robotic totally endoscopic coronary artery bypass grafting hybrid procedure.

Eric J Lehr1, Patrick Odonkor, Peter Reyes, Johannes Bonatti.   

Abstract

Robotically assisted totally endoscopic coronary artery bypass grafting (TECAB) can be performed on the beating heart with cardiopulmonary bypass support in high-risk patients or patients for whom technical difficulties are expected with a complete off-pump approach. To minimize the inflammatory response and reduce the requirement for transfusion, minimized extracorporeal circulation is an attractive option for robotic TECAB procedures. The present report describes a case for which minimized extracorporeal circulation was used for the first time in TECAB performed using the da Vinci telemanipulation system.

Entities:  

Mesh:

Year:  2010        PMID: 20847981      PMCID: PMC2950724          DOI: 10.1016/s0828-282x(10)70429-3

Source DB:  PubMed          Journal:  Can J Cardiol        ISSN: 0828-282X            Impact factor:   5.223


  3 in total

1.  Clinical experience with the mini-extracorporeal circulation system: an evolution or a revolution?

Authors:  Jean-Paul Remadi; Paul Marticho; Irina Butoi; Zava Rakotoarivelo; Faouzi Trojette; Amar Benamar; Sadek Beloucif; Dominique Foure; Henri J Poulain
Journal:  Ann Thorac Surg       Date:  2004-06       Impact factor: 4.330

2.  Robotically Assisted Beating Heart Totally Endoscopic Coronary Artery Bypass (TECAB). Is There a Future?

Authors:  Sudhir Srivastava; Suresh Gadasalli; Madhava Agusala; Ram Kolluru; Reyna Barrera; Shaune Quismundo; Vishwa Srivastava; Usha Seshadri-Kreaden
Journal:  Innovations (Phila)       Date:  2008-03

3.  On-pump beating-heart with axillary artery perfusion: a solution for robotic totally endoscopic coronary artery bypass grafting?

Authors:  Johannes Bonatti; Jose Garcia; Atiq Rehman; Patrick Odonkor; Reyaz Haque; David Zimrin; Bartley Griffith
Journal:  Heart Surg Forum       Date:  2009-06       Impact factor: 0.676

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.